USSTOCK.TODAY
Regular Market
Log in Sign up

Riesel Pharmaceuticals eyes Vepinu launch performance ahead of Q3 earnings

Earnings Whispers · ·by G4L

RIGL
RIGL Rigel Pharmaceuticals
$43.91 +4.42%
View chart & analysis →
  1. 1Riesel Pharmaceuticals will announce third-quarter results after market close on November 5.
  2. 2Riesel Pharmaceuticals' expected earnings per share of $0.87 represents a decrease of approximately 40% from $1.46 in the same period last year.
  3. 3Riesel Pharmaceuticals' revenue consensus of $78.3 million represents a 12.7% increase from $69.5 million last year.

So what's the key point?

Riesel Pharmaceuticals is releasing its third-quarter results on November 5. Earnings are expected to decrease to $0.87, but revenue is expected to increase.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Rigel Pharmaceuticals Records $72.3 Million in Net Product Sales for Q3 2026 The Motley Fool +1 · 5d agoQuad raises revenue guidance but lowers adjusted EBITDA and long-term targets Earnings Whispers · Oct 30Monster Beverage faces growth slowdown concerns ahead of Q3 earnings release Earnings Whispers · Oct 30
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news